iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

GPT Healthcare IPO Subscription latest status

19 Mar 2024 , 10:34 AM

The price range for the GPT Healthcare initial public offering (IPO) is ₹177 to ₹186 per equity share, with a face value of ₹10. Eighty equity shares make up a GPT IPO lot, and additional lots of eighty equity shares are available.

The IPO of GPT Healthcare on Thursday, February 22nd, raised ₹157.54 Crores from anchor investors. The exchanges were informed by the company that it had allotted 84,69,996 equity shares at a price of ₹186 each.

Under the 'ILS Hospitals' brand, GPT Healthcare Ltd. manages a network of mid-sized full-service hospitals that offer integrated healthcare services, with an emphasis on secondary and tertiary care.

While revenue increased by 7.11%, GPT Healthcare Limited's profit after tax (PAT) decreased by -6.37% between March 31, 2022, and March 31, 2023.

The ₹525.14 Crore GPT Healthcare IPO consists of an offer-for-sale (OFS) of 26,082,786 equity shares of ₹10, totaling ₹485.14 Crore, made by the investor selling shareholder, BanyanTree Growth Capital II, LLC, and a new issue of ₹40 Crore.

The firm plans to use the net proceeds to achieve the following purposes: general corporate objectives; repayment of some of its outstanding debts from banks and financial institutions, either fully or partially.

JM Financial Limited is the book running lead manager for the GPT Healthcare IPO, while Link Intime India Private Ltd. is the issue registrar.

The subscription period for the GPT Healthcare IPO began on Thursday, February 22, and it ends on Monday, February 26. 37% of subscribers to the GPT Healthcare IPO were active on the first day. At 123% of the issue's retail portion was oversubscribed, 79% of it was booked for non-institutional investors (NIIs), and 19% of the qualified institutional buyer (QIB) portion was subscribed.

For feedback and suggestions, write to us at editorial@iifl.com

GPT Healthcare IPO - Review & Fundamental Analysis

Related Tags

  • GPT Healthcare
  • IPO
  • subscription
sidebar mobile

BLOGS AND PERSONAL FINANCE

Images
15 Apr 2024   |   12:16 PM
Images
15 Apr 2024   |   10:33 AM
Images
15 Apr 2024   |   09:44 AM
Read More

Most Read News

15 Apr 2024   |   08:44 PM
15 Apr 2024   |   08:41 PM
15 Apr 2024   |   08:40 PM
15 Apr 2024   |   08:40 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

closeIcon

Get better recommendations & make better investments

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp